バイオイメージング市場：技術、エンドユーザー、用途別-2025-2030年の世界予測

バイオイメージング市場は、2023年に16億9,000万米ドルと評価され、2024年には18億6,000万米ドルに達すると予測され、CAGR 10.15％で成長し、2030年には33億3,000万米ドルに達すると予測されています。

バイオイメージング市場には、主に臨床および研究目的で、生体内の生物学的プロセスを可視化するために使用される幅広い技術と方法が含まれます。この市場には、MRI、CT、超音波、PET、光イメージングなどのモダリティが含まれ、それぞれ疾患診断、薬剤開発、バイオテクノロジー研究などに独自の用途があります。バイオイメージングの必要性は、非侵襲的に疾患の進行を追跡し、個別化医療を可能にし、がんや神経疾患などの疾患の早期発見を容易にするという、その本質的な役割から生じています。その用途は臨床診断からライフサイエンス研究まで幅広く、細胞メカニズムの解明、治療効果の評価、創薬の実施に役立っています。最終用途の範囲には、病院、診断センター、研究機関、製薬会社などが含まれ、これらの企業は患者の転帰を改善し、科学的理解を進めるためにこれらの技術を必要としています。

市場成長の原動力は、技術の進歩、低侵襲診断手技に対する需要の増加、慢性疾患の有病率の上昇です。画像解析や診断精度を向上させるためのAIや機械学習の応用拡大や、画像技術の革新を目指すバイオテクノロジー企業の研究開発投資の拡大がチャンスとなります。しかし、課題としては、高い機器コスト、規制上のハードル、熟練した専門家の不足などがあります。これらを克服するためには、技術開発者とヘルスケアプロバイダーがパートナーシップを結び、費用対効果の高いソリューションを構築することが重要です。さらに、データの保存と分析にクラウド・コンピューティングを活用すれば、システムの効率を高め、コストを削減することができます。

AIベースの診断ツールの統合や、遠隔地でのアクセシビリティを高めるポータブル画像診断機器の開発によって、イノベーションを先導することができます。バイオイメージング市場はダイナミックな成長を示しており、精密医療と個別化治療計画への依存が高まっているため、利害関係者はこれらの進歩を優先する戦略を採用することが極めて重要です。分子イメージングにおいてより詳細なコントラストを提供できる新規イメージング薬剤の調査により、市場のさらなる可能性が開ける可能性があります。このように、バイオイメージングで新たなビジネスチャンスを活かそうと躍起になっている企業にとって、技術動向の把握と効率的な規制のナビゲーションは不可欠です。

市場力学：急速に進化するバイオイメージング市場の主要市場インサイトを公開

バイオイメージング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢化人口の増加に伴う疾病の早期診断ニーズの高まり
  • 世界各地の病院数および診断センター数の増加
  • バイオイメージングに対する規制当局の好意的な承認と、診断ソリューションへのアクセス提供に対する政府の支援
• 市場抑制要因
  • バイオイメージングの実施における複雑さと熟練者の必要性
• 市場機会
  • バイオイメージング技術の技術革新による機能と性能の向上
  • 個別化医療におけるバイオイメージングソリューションの採用
• 市場の課題
  • 解像度、明瞭度、処理時間に関する懸念

ポーターの5つの力：バイオイメージング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオイメージング市場における外部からの影響の把握

外部マクロ環境要因は、バイオイメージング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオイメージング市場における競合情勢の把握

バイオイメージング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオイメージング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオイメージング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオイメージング市場における成功への道筋を描く

バイオイメージング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化社会の進展に伴い、疾病の早期診断の必要性が高まっている
    • 世界中の病院と診断センターの数の増加
    • バイオイメージングに対する規制当局の承認と、診断ソリューションへのアクセスを提供するための政府の支援
  • 抑制要因
    • バイオイメージングの実行の複雑さと熟練した人材の必要性
  • 機会
    • バイオイメージングテクノロジーの機能性と性能を向上させる技術革新
    • 個別化医療におけるバイオイメージングソリューションの採用
  • 課題
    • 解像度、鮮明度、処理時間に関する懸念
• 市場セグメンテーション分析
  • テクノロジー：X線画像の効率と安全性を向上させる新たなイノベーション
  • エンドユーザー：世界中の病院の拡大と包括的なヘルスケアソリューションの提供
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオイメージング市場：技術別

• コンピュータ断層撮影
• 磁気共鳴画像
• 光学イメージング
• 陽電子放出断層撮影
• 単一光子放出コンピュータ断層撮影
• 超音波
• X線画像

第7章 バイオイメージング市場：エンドユーザー別

• クリニック
• 診断センター
• 病院
• 研究所

第8章 バイオイメージング市場：用途別

• 農業調査
• 臨床診断
• 医薬品の発見と開発
• 調査室

第9章 南北アメリカのバイオイメージング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のバイオイメージング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオイメージング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 英国とインドが協力し、画期的な望遠鏡プロジェクトに向けたビッグデータの課題に取り組む
  • HSSとMARS Bioimagingが協力し、CERNの高度な光子計数CT技術を使用して筋骨格イメージングに革命を起こす
• 戦略分析と提言

企業一覧

• BaySpec, Inc.
• Bracco S.p.A.
• Bruker Corporation
• Canon Medical Systems Corporation
• Esaote S.p.A
• Fujifilm Holdings Corporation
• GE HealthCare Technologies, Inc.
• iThera Medical GmbH
• Kitware, Inc.
• Koninklijke Philips N.V.
• Lantheus Medical Imaging, Inc.
• M Squared Lasers Ltd.
• MARS Bioimaging Limited
• Medtronic PLC
• MobileODT
• Nanoco Group PLC
• Perspectum Ltd.
• Positron Corporation
• Quibim, S.L.
• RadNet, Inc.
• Rivanna Medical, Inc.
• Samsung Medison Co., Ltd.
• Siemens Healthineers AG

LIST OF FIGURES

• FIGURE 1. BIO-IMAGING MARKET RESEARCH PROCESS
• FIGURE 2. BIO-IMAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIO-IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY AGRICULTURAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CANADA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. CHINA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. CHINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. INDIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. INDIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. ITALY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. ITALY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. POLAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. POLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. QATAR BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. QATAR BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 153. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Bio-imaging Market was valued at USD 1.69 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 10.15%, to USD 3.33 billion by 2030.

The bio-imaging market encompasses a wide range of technologies and methods used to visualize biological processes in living organisms, primarily for clinical and research purposes. It includes modalities such as MRI, CT, ultrasound, PET, and optical imaging, each with unique applications in disease diagnosis, drug development, and biotechnology research. The necessity of bio-imaging arises from its essential role in non-invasively tracing disease progress, enabling personalized medicine, and facilitating early detection of conditions such as cancer and neurological disorders. Its application spans from clinical diagnostics to life sciences research, where it aids in understanding cellular mechanisms, evaluating therapeutic efficacy, and conducting drug discovery. The end-use scope includes hospitals, diagnostic centers, research institutions, and pharmaceutical companies, which demand these technologies to improve patient outcomes and advance scientific understanding.

Market growth is driven by technological advancements, increasing demand for minimally invasive diagnostic procedures, and rising prevalence of chronic diseases. Opportunities lie in expanding applications of AI and machine learning to improve image analysis and diagnostic accuracy, alongside growing investments in R&D from biotech firms aiming at innovation in imaging technologies. However, challenges include high equipment costs, regulatory hurdles, and a scarcity of skilled professionals. To overcome these, partnerships between technology developers and healthcare providers to create cost-effective solutions could be vital. Moreover, leveraging cloud computing for data storage and analysis can augment system efficiencies and reduce costs.

Innovation can be spearheaded by integrating AI-based diagnostic tools and the development of portable imaging devices, enhancing accessibility in remote areas. The bio-imaging market exhibits dynamic growth, with increasing reliance on precision medicine and personalized treatment plans, making it crucial for stakeholders to adopt strategies that prioritize these advancements. Research into novel imaging agents that can provide more detailed contrast in molecular imaging could unlock further potential in the market. Thus, staying abreast of technological trends and efficient regulatory navigation is essential for businesses eager to capitalize on emerging opportunities in bio-imaging.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bio-imaging Market

The Bio-imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for early diagnosis of diseases with the rise in the aging population
  • Rise in the number of hospitals and diagnostic centers across the world
  • Favorable regulatory approvals for bio-imaging and government support for providing access to diagnostics solutions
• Market Restraints
  • Complexities in performing bio-imaging and the need for skilled personnel
• Market Opportunities
  • Technological innovations in bio-imaging technology to improve its functionality and performance
  • Adoption of bio-imaging solutions in personalized medicine
• Market Challenges
  • Concerns related to resolution, clarity, and processing time

Porter's Five Forces: A Strategic Tool for Navigating the Bio-imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bio-imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bio-imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bio-imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bio-imaging Market

A detailed market share analysis in the Bio-imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bio-imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bio-imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bio-imaging Market

A strategic analysis of the Bio-imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bio-imaging Market, highlighting leading vendors and their innovative profiles. These include BaySpec, Inc., Bracco S.p.A., Bruker Corporation, Canon Medical Systems Corporation, Esaote S.p.A, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., iThera Medical GmbH, Kitware, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., M Squared Lasers Ltd., MARS Bioimaging Limited, Medtronic PLC, MobileODT, Nanoco Group PLC, Perspectum Ltd., Positron Corporation, Quibim, S.L., RadNet, Inc., Rivanna Medical, Inc., Samsung Medison Co., Ltd., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Bio-imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Optical Imaging, Positron Emission Tomography, Single-Photon Emission Computed Tomography, Ultrasound, and X-ray Imaging.
• Based on End-User, market is studied across Clinics, Diagnostic Centers, Hospitals, and Laboratories.
• Based on Application, market is studied across Agricultural Research, Clinical Diagnostics, Drug Discovery & Development, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for early diagnosis of diseases with the rise in the aging population
    • 5.1.1.2. Rise in the number of hospitals and diagnostic centers across the world
    • 5.1.1.3. Favorable regulatory approvals for bio-imaging and government support for providing access to diagnostics solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in performing bio-imaging and the need for skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations in bio-imaging technology to improve its functionality and performance
    • 5.1.3.2. Adoption of bio-imaging solutions in personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to resolution, clarity, and processing time
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Emerging innovations to improve the efficiency and safety of x-ray imaging
  • 5.2.2. End-User: Expansion of hospitals across the world and provision of comprehensive healthcare solutions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bio-imaging Market, by Technology

• 6.1. Introduction
• 6.2. Computed Tomography
• 6.3. Magnetic Resonance Imaging
• 6.4. Optical Imaging
• 6.5. Positron Emission Tomography
• 6.6. Single-Photon Emission Computed Tomography
• 6.7. Ultrasound
• 6.8. X-ray Imaging

7. Bio-imaging Market, by End-User

• 7.1. Introduction
• 7.2. Clinics
• 7.3. Diagnostic Centers
• 7.4. Hospitals
• 7.5. Laboratories

8. Bio-imaging Market, by Application

• 8.1. Introduction
• 8.2. Agricultural Research
• 8.3. Clinical Diagnostics
• 8.4. Drug Discovery & Development
• 8.5. Research Laboratories

9. Americas Bio-imaging Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bio-imaging Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bio-imaging Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. UK and India Unite to Tackle Big Data Challenges for Groundbreaking Telescope Project
  • 12.3.2. HSS and MARS Bioimaging Collaborate to Revolutionize Musculoskeletal Imaging with Advanced Photon-Counting CT Technology from CERN
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BaySpec, Inc.
• 2. Bracco S.p.A.
• 3. Bruker Corporation
• 4. Canon Medical Systems Corporation
• 5. Esaote S.p.A
• 6. Fujifilm Holdings Corporation
• 7. GE HealthCare Technologies, Inc.
• 8. iThera Medical GmbH
• 9. Kitware, Inc.
• 10. Koninklijke Philips N.V.
• 11. Lantheus Medical Imaging, Inc.
• 12. M Squared Lasers Ltd.
• 13. MARS Bioimaging Limited
• 14. Medtronic PLC
• 15. MobileODT
• 16. Nanoco Group PLC
• 17. Perspectum Ltd.
• 18. Positron Corporation
• 19. Quibim, S.L.
• 20. RadNet, Inc.
• 21. Rivanna Medical, Inc.
• 22. Samsung Medison Co., Ltd.
• 23. Siemens Healthineers AG